Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Indomethacin: antitumor activity and effects on telomerase

Dec. 17, 1997

Clinical evaluation of adenoviral-p53 gene therapy for prostate cancer begins

Dec. 17, 1997

Burzynski's antineoplastons in phase II testing for multiple oncology indications

Dec. 17, 1997

Neovascularization inhibitors from Tsumura Juntendo

Dec. 17, 1997

Farnesyltransferase inhibitors claimed by Banyu

Dec. 17, 1997

Aronex presents preliminary phase II results on Atragen

Dec. 16, 1997

Second-generation antisense antitumor compound from Hybridon enters clinic

Dec. 16, 1997

Total synthesis of aglaiastatin C, a natural antitumor alkaloid

Dec. 15, 1997

New FPP-based inhibitor of protein farnesyltransferase discovered at Banyu

Dec. 15, 1997

Eisai develops novel retinoids as highly potent and selective RXR agonists

Dec. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...